Stock listing

A2PCBU Stock Price, News, Filings & Events — Inmune Bio Inc.

Selected listing: A2PCBU · LS · EUR · DE

The selected listing A2PCBU:LS represents Inmune Bio Inc., a biotechnology company focused on developing therapies to treat neurodegenerative diseases and cancer. The company is actively engaged in clinical trials and research to advance its innovative treatments. Recent news includes updates on their ongoing studies and strategic partnerships aimed at enhancing their product pipeline. Investors can find relevant filings and upcoming events that may impact the company's market presence and growth potential.

A2PCBU:LSEURDEUpdated July 24, 2026
Inmune Bio Inc. logo
Ticker
A2PCBU:LS
Asset type
Stock
Market cap
$43.1M
Sector
Health Technology
Industry
Biotechnology
Exchange
LS
Currency
EUR

Inmune Bio Inc. A2PCBU:LS stock context

The selected listing A2PCBU:LS represents Inmune Bio Inc., a biotechnology company focused on developing therapies to treat neurodegenerative diseases and cancer. The company is actively engaged in clinical trials and research to advance its innovative treatments. Recent news includes updates on their ongoing studies and strategic partnerships aimed at enhancing their product pipeline. Investors can find relevant filings and upcoming events that may impact the company's market presence and growth potential.

Research Inmune Bio Inc.

Alternate listings